Search results
Results from the WOW.Com Content Network
Jörg Reinhardt (born 11 March 1956) is a German businessman who has been the chairman of the board of directors of the Swiss pharmaceutical group Novartis AG since 2013. [1] [2] Since 2017, he has also been a member of the board of directors of the Swiss reinsurance group Swiss Re.
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. [1] The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.
Novartis AG also held 33.3 percent of the shares of Roche until 2022, however it did not exercise control over Roche. [122] Novartis also has two significant license agreements with Genentech, a Roche subsidiary. [123] One agreement is for Lucentis; [124] the other is for Xolair. [125] [121]: 239
Novartis is poised to prevail in the auction for Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson, according to the source. A deal could be announced as early as ...
Chiron Corporation (/ ˈ k aɪ r ɒ n / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006.
Medicare Advantage Open Enrollment Period: If a person is already in a Medicare Advantage plan, they can switch or drop their plan between January 1 to March 31. A person is also eligible to make ...
We're discussing the new Bob Dylan biopic "A Complete Unknown" (in theaters now). If you haven't seen it, don't think twice, bookmark our story for later. If you haven't seen it, don't think twice ...
Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.